Published in Br J Pharmacol on September 01, 1999
Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev (2013) 2.42
Agonist-selective mechanisms of GPCR desensitization. Br J Pharmacol (2007) 2.17
Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease. Pharmacol Rev (2011) 1.38
Role of protein kinase C and mu-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons. Eur J Neurosci (2009) 1.34
Morphine tolerance in the mouse ileum and colon. J Pharmacol Exp Ther (2008) 1.31
A novel Gbetagamma-subunit inhibitor selectively modulates mu-opioid-dependent antinociception and attenuates acute morphine-induced antinociceptive tolerance and dependence. J Neurosci (2008) 1.20
How to design an opioid drug that causes reduced tolerance and dependence. Ann Neurol (2010) 1.09
Shared mechanisms for opioid tolerance and a transition to chronic pain. J Neurosci (2010) 1.00
Pre-treatment with a PKC or PKA inhibitor prevents the development of morphine tolerance but not physical dependence in mice. Brain Res (2008) 0.96
Mapping of a quantitative trait locus for morphine withdrawal severity. Mamm Genome (2004) 0.93
Chronic morphine induces the concomitant phosphorylation and altered association of multiple signaling proteins: a novel mechanism for modulating cell signaling. Proc Natl Acad Sci U S A (2001) 0.91
Supraspinal Gbetagamma-dependent stimulation of PLCbeta originating from G inhibitory protein-mu opioid receptor-coupling is necessary for morphine induced acute hyperalgesia. J Neurochem (2009) 0.86
Evidence for an important role of protein phosphatases in the mechanism of morphine tolerance. Brain Res (2007) 0.86
Reciprocal modulation of phospholipase Cbeta isoforms: adaptation to chronic morphine. Proc Natl Acad Sci U S A (2003) 0.86
Heterologous regulation of agonist-independent μ-opioid receptor phosphorylation by protein kinase C. Br J Pharmacol (2014) 0.85
TOR and PKA pathways synergize at the level of the Ste11 transcription factor to prevent mating and meiosis in fission yeast. PLoS One (2010) 0.83
Rhes: a GTP-binding protein integral to striatal physiology and pathology. Cell Mol Neurobiol (2012) 0.79
Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats. Brain Res (2007) 0.78
Possible mechanism of protective effect of thalidomide in STZ-induced-neuropathic pain behavior in rats. Inflammopharmacology (2011) 0.77
Mice lacking rhes show altered morphine analgesia, tolerance, and dependence. Neurosci Lett (2010) 0.77
Contribution of acid sphingomyelinase in the periaqueductal gray region to morphine-induced analgesia in mice. Neuroreport (2012) 0.75
Phosphatidylethanolamine-binding protein is not involved in µ-opioid receptor-mediated regulation of extracellular signal-regulated kinase. Mol Med Rep (2015) 0.75
Impact of human CA8 on thermal antinociception in relation to morphine equivalence in mice. Neuroreport (2017) 0.75
The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem J (1990) 3.44
Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc Natl Acad Sci U S A (1998) 3.07
Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma. Science (1997) 2.98
Role of phospholipase in generating lipid second messengers in signal transduction. FASEB J (1991) 2.56
SOME NARCOTIC ANTAGONISTS IN THE BENZOMORPHAN SERIES. J Pharmacol Exp Ther (1964) 2.18
The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J Pharmacol Exp Ther (1970) 2.01
Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology. Prog Brain Res (1991) 1.88
Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice. J Pharmacol Exp Ther (1975) 1.52
Phase-dependent contributions from Ca2+ entry and Ca2+ release to caffeine-induced [Ca2+]i oscillations in bullfrog sympathetic neurons. Neuron (1992) 1.36
Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice. J Pharmacol Exp Ther (1996) 1.26
Expression, purification, and characterization of the G protein-coupled receptor kinase GRK5. J Biol Chem (1994) 1.13
Reg1ulatory role and molecular interactions of a cell-surface heparan sulfate proteoglycan (N-syndecan) in hippocampal long-term potentiation. J Neurosci (1999) 1.01
Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine. Brain Res (1995) 1.01
Relationship of brain morphine levels to analgesic activity in acutely treated mice and rats and in pellet implanted mice. J Pharmacol Exp Ther (1975) 0.98
Involvement of intracellular calcium in morphine tolerance in mice. Pharmacol Biochem Behav (1999) 0.97
Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse. Br J Pharmacol (1996) 0.96
Desensitization of the delta-opioid receptor correlates with its phosphorylation in SK-N-BE cells: involvement of a G protein-coupled receptor kinase. J Neurochem (1998) 0.96
Influence of chronic morphine treatment on protein kinase C activity: comparison with butorphanol and implication for opioid tolerance. Brain Res (1994) 0.95
Anatomy, physiology and pharmacology of the periaqueductal gray contribution to antinociceptive controls. Prog Brain Res (1988) 0.93
Chronic inhibition of intracellular Ca2+ release or protein kinase C activation significantly reduces the development of morphine dependence. Eur J Pharmacol (1996) 0.93
Is low molecular weight heparin a neuroprotectant? Ann N Y Acad Sci (1997) 0.92
Inhibitors of phosphatidylinositol signalling as antiproliferative agents. Cancer Metastasis Rev (1994) 0.86
Modulation of immunoreactive protein kinase C-alpha and beta isoforms and G proteins by acute and chronic treatments with morphine and other opiate drugs in rat brain. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.86
Nociceptin-induced apparent hyperalgesia in mice as a result of the prevention of opioid autoanalgesic mechanisms triggered by the stress of an intracerebroventricular injection. Fundam Clin Pharmacol (1998) 0.86
Effects of spinal versus supraspinal administration of cyclic nucleotide-dependent protein kinase inhibitors on morphine tolerance in mice. Drug Alcohol Depend (1997) 0.85
Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered mu-opioid receptor agonist in the mouse. Eur J Pharmacol (1995) 0.84
Desensitization and resensitization of delta-opioid receptor-mediated Ca2+ channel inhibition in NG108-15 cells. Br J Pharmacol (1998) 0.83
Attenuation of morphine withdrawal symptoms by subtype-selective metabotropic glutamate receptor antagonists. Br J Pharmacol (1997) 0.81
Calcium modulation of morphine analgesia: role of calcium channels and intracellular pool calcium. J Pharmacol Exp Ther (1995) 0.81
Possible involvement of protein kinase C in the attenuation of [D-Ala2, NMePhe4, Gly-ol5]enkephalin-induced antinociception in diabetic mice. Eur J Pharmacol (1997) 0.80
Pretreatment with protein kinase C activator phorbol 12,13-dibutyrate attenuates the antinociception induced by mu- but not epsilon-opioid receptor agonist in the mouse. Neuroscience (1997) 0.79
Cannabinoid pharmacology. Pharmacol Rev (1986) 2.15
The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J Pharmacol Exp Ther (1970) 2.01
A survey of the teaching of pain control at the predoctoral level. Anesth Prog (1976) 1.93
Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice. J Pharmacol Exp Ther (1975) 1.52
Beta-endorphin in cerebrospinal fluid and serum after severe head injury. Neurosurgery (1990) 1.42
Involvement of PKC alpha and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of mu-opioid receptors in mature brain neurons. Br J Pharmacol (2009) 1.38
Role of protein kinase C and mu-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons. Eur J Neurosci (2009) 1.34
The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy. J Pharmacol Exp Ther (2009) 1.27
Narcotic-antagonist analgesics: interactions with cholinergic systems. J Pharmacol Exp Ther (1969) 1.17
Antineoplastic activity of cannabinoids. J Natl Cancer Inst (1975) 1.14
Optically pure (+)-nicotine from (+/-)-nicotine and biological comparisons with (-)-nicotine. J Med Chem (1979) 1.12
Pharmacology of some marijuana constituents and 2 heterocyclic analogues. Nature (1970) 1.11
Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine. J Pharmacol Exp Ther (1981) 1.02
Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance. Br J Pharmacol (2007) 1.00
A cannabinoid with cardiovascular activity but no overt behavioral effects. Experientia (1977) 1.00
Relationship of brain morphine levels to analgesic activity in acutely treated mice and rats and in pellet implanted mice. J Pharmacol Exp Ther (1975) 0.98
Involvement of intracellular calcium in morphine tolerance in mice. Pharmacol Biochem Behav (1999) 0.97
Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat. J Pharmacol Exp Ther (1976) 0.94
Discriminative stimulus and neurochemical mechanism of cathinone: a preliminary study. NIDA Res Monogr (1979) 0.90
Some pharmacological and toxicological effects of 1-trans- 8 and 1-trans- 9 -tetrahydrocannabinol in laboratory rodents. Arch Int Pharmacodyn Ther (1972) 0.90
The spinal cord as a major site for the antinociceptive action of nicotine in the rat. Neuropharmacology (1986) 0.89
Reversal of morphine analgesic tolerance by ethanol in the mouse. J Pharmacol Exp Ther (2013) 0.89
Distribution of radioactivity in brain of tolerant and nontolerant pigeons treated with 3 H- 9 -tetrahydrocannabinol. Biochem Pharmacol (1973) 0.88
Antipyretic, analgesic and anti-inflammatory effects of delta 9-tetrahydrocannabinol in the rat. Eur J Pharmacol (1973) 0.87
The effects of chronic administration of trans- 9 -tetrahydrocannabinol on behavior and the cardiovascular system of dogs. Arch Int Pharmacodyn Ther (1972) 0.87
The effect of 1-trans-delta 9-tetrahydrocannabinol on the hypothalamo-hypophyseal-adrenal axis of rats. Eur J Pharmacol (1970) 0.86
Site and mechanism of morphine tolerance in the gastrointestinal tract. Neurogastroenterol Motil (2014) 0.86
Some 9-hydroxycannabinoid-like compounds. Synthesis and evaluation of analgesic and behavioral properties. J Med Chem (1979) 0.85
The antinociception produced by intrathecal morphine, calcium, A23187, U50,488H, [D-Ala2, N-Me-Phe4, Gly-ol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice. J Pharmacol Exp Ther (1989) 0.85
Neonatal pain: a comprehensive survey of attitudes and practices. J Pain Symptom Manage (1993) 0.85
Cardiovascular effects of delta 9- and delta 9(11)-tetrahydrocannabinol and their interaction with epinephrine. Life Sci (1987) 0.85
Further studies on the antinociceptive effects of delta 6-THC-7-oic acid. Agents Actions (1990) 0.84
Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes. J Pharmacol Exp Ther (1980) 0.84
Plasma beta-endorphin immunoreactivity: response to resistance exercise. J Sports Sci (1993) 0.84
The effect of morphine, nalorphine, naloxone, pentazocine, cyclazocine and oxotremorine on the synthesis and release of acetylcholine by mouse cerebral cortex slices in vitro. Arch Int Pharmacodyn Ther (1970) 0.84
Behavioral comparisons of the stereoisomers of tetrahydrocannabinols. Life Sci (1981) 0.83
Enhanced susceptibility of mice to combinations of delta 9-tetrahydrocannabinol and live or killed gram-negative bacteria. Infect Immun (1977) 0.83
Interactions of thyrotropin releasing hormone and morphine sulfate in rodents. Life Sci (1977) 0.83
Effects of beta-funaltrexamine (beta-FNA) on morphine dependence in rats and monkeys. Eur J Pharmacol (1986) 0.83
The effect of hypophysectomy on acupuncture analgesia in the mouse. Brain Res (1980) 0.83
Cannabis dependence and tolerance production. Adv Alcohol Subst Abuse (1990) 0.82
3H-delta9-tetrahydrocannabinol tissue and subcellular distribution in the central nervous system and tissue distribution in peripheral organs of tolerant and nontolerant dogs. J Pharmacol Exp Ther (1976) 0.82
Dynorphin-(1-13): effects in nontolerant and morphine-dependent rhesus monkeys. Eur J Pharmacol (1982) 0.82
Cholinergic agents: antinociception without morphine type dependence in rats. Life Sci (1985) 0.82
Sensitization of enteric neurons to morphine by HIV-1 Tat protein. Neurogastroenterol Motil (2015) 0.81
Disposition of morphine in chronically infused rats: relationship to antinociception and tolerance. J Pharmacol Exp Ther (1978) 0.81
Increased cerebrospinal fluid beta-endorphin immunoreactivity in infants with apnea and in siblings of victims of sudden infant death syndrome. J Pediatr (1987) 0.81
Hypoglycemia induced by intrathecal opioids in mice: stereospecificity, drug specificity and effect of fasting. J Pharmacol Exp Ther (1990) 0.81
3H-delta9-tetrahydrocannabinol distribution in pregnant dogs and their fetuses. Res Commun Chem Pathol Pharmacol (1977) 0.80
A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse. Psychopharmacology (Berl) (1978) 0.80
Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain. Diabetes (1987) 0.80
Water-soluble derivatives of 1 -tetrahydrocannabinol. Science (1972) 0.79
Antinociceptive action of the butyryl derivatives of cyclic guanosine 3':5'-monophosphate. J Pharmacol Exp Ther (1978) 0.79
The effect of narcotics and narcotic antagonists on the tail-flick response in spinal mice. J Pharm Pharmacol (1969) 0.79
Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain. Alcohol Drug Res (1987) 0.79
Blood levels of 3 H- 9 -tetrahydrocannabinol and its metabolites in tolerant and nontolerant pigeons. Biochem Pharmacol (1973) 0.79
Endogenous opioids released by suspending mice by the tail selectively enhance spinal mu opioid analgesia. J Pharmacol Exp Ther (1994) 0.79
Brain acetylcholine levels and inhibition of the tail-flick reflex in mice. J Pharmacol Exp Ther (1969) 0.79
The mouse paw withdrawal assay: a method for determining the effect of calcitonin gene-related peptide on cutaneous heat nociceptive latency time. Life Sci (1993) 0.78
A proposed mechanism of action for the antinociceptive effect of intrathecally administered calcium in the mouse. J Pharmacol Exp Ther (1992) 0.78
Effect of propranolol on antinociceptive and withdrawal characteristics of morphine. Pharmacol Biochem Behav (1976) 0.78
3H-delta 9-Tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: penetration and regional distribution in rat brain. Pharmacol Biochem Behav (1980) 0.78
Effects of delta9-tetrahydrocannabinol on neurotransmitter accumulation and release mechanisms in rat forebrain synaptosomes. Life Sci (1976) 0.78
A comparison of some stereochemical requirements of the acetylcholinesterase and muscarinic receptor areas. J Med Chem (1970) 0.78
A comparison of the antinociceptive effects of opioid agonists in neonatal and adult rats in phasic and tonic nociceptive tests. Pharmacol Biochem Behav (1994) 0.78
Alterations in the pharmacokinetics of 3H-delta9-tetrahydrocannabinol in mice by bacterial endotoxin. Drug Metab Dispos (1978) 0.78
Effects of divalent cations, lanthanum, cation chelators and an ionophore on acetylcholine antinociception. J Pharmacol Exp Ther (1978) 0.78
Apparent in vivo acetylcholine turnover rate in whole mouse brain: evidence for a two compartment model by two independent kinetic analyses. J Neurochem (1979) 0.77
Studies on the mechanism of hypoglycemia induced by intrathecal morphine: dissociation from behavioral effects, effects of tolerance and depletion of liver glycogen. J Pharmacol Exp Ther (1989) 0.77
Elevated CSF beta-endorphin immunoreactivity in Rett's syndrome: report of 158 cases and comparison with leukemic children. Neurology (1992) 0.77
Morphine tolerance-induced modulation of [3H]glyburide binding to mouse brain and spinal cord. Drug Alcohol Depend (1997) 0.77
Cannabinoid effects on plasma corticosterone and uptake of 3H-corticosterone by mouse brain. Eur J Pharmacol (1978) 0.77
Pharmacological potency of R- and S-3'-hydroxy-delta 9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity. Pharmacol Biochem Behav (1984) 0.77
Comparison of the antinociceptive activity of intraventricularly administered acetylcholine to narcotic antinociception. Neurosci Lett (1981) 0.77
9-nor-9beta-hydroxyhexahydrocannabinol, a cannabinoid with potent antinociceptive activity: comparisons with morphine. J Pharmacol Exp Ther (1977) 0.77
Distribution of radioactivity in the spinal cord after intracerebroventricular and intravenous injection of radiolabeled opioid peptides in mice. J Pharmacol Exp Ther (1982) 0.77
delta 9-THC and 11-OH-delta 9-THC: behavioral effects and relationship to plasma and brain levels. Life Sci (1977) 0.77
A comparison of antinociception induced by foot shock and morphine. J Pharmacol Exp Ther (1983) 0.77
Differential effects of subcutaneous and intrathecal morphine administration on blood glucose in mice: comparison with intracerebroventricular administration. J Pharmacol Exp Ther (1988) 0.77
The role of endogenous peptides in the action of opioid analgesics. Ann Emerg Med (1986) 0.77
Narcotics and diabetes. II. Streptozotocin-induced diabetes selectively alters the potency of certain narcotic analgesics. Mechanism of diabetes: morphine interaction. J Pharmacol Exp Ther (1981) 0.76
Annual report: dependence studies of new compounds in the rhesus monkey (1980). NIDA Res Monogr (1981) 0.76
An insulin-independent mechanism of intrathecal morphine-induced hypoglycemia in mice: mediation through a central alpha-2 adrenergic pathway. J Pharmacol Exp Ther (1991) 0.76
Some structural requirements for inhibition of high-affinity synaptosomal serotonin uptake by cannabinoids. Mol Pharmacol (1976) 0.76
Stereoselective stimulus effects of 3-methylflunitrazepam and pentobarbital. Life Sci (1984) 0.76
Morphine dependence and diabetes. II. Alterations of normorphine potency in the guinea-pig ileum and mouse vas deferens and of ileal morphine dependence by changes in glucose concentration. J Pharmacol Exp Ther (1986) 0.76
The effects of cannabinoids on body temperature and brain catecholamine synthesis. Res Commun Chem Pathol Pharmacol (1978) 0.76
The role of neurotransmitters in stress-induced antinociception (SIA). Pharmacol Biochem Behav (1982) 0.76
Stereoselective effect of morphine on antinociception and endogenous opioid peptide levels in plasma but not cerebrospinal fluid of dogs. Life Sci (1991) 0.76
Differential effects of divalent cations, cation chelators and an ionophore (A23187) on morphine and dibutyryl guanosine 3': 5'-cyclic monophosphate antinociception. J Pharmacol Exp Ther (1980) 0.76
Fentanyl self-administration in juvenile rats that were tolerant and dependent to fentanyl as infants. Pharmacol Biochem Behav (2000) 0.76
The central and peripheral effects of delta-9-tetrahydrocannabinol on gastrointestinal transit in mice. NIDA Res Monogr (1986) 0.76
Marihuana-like activity of new synthetic tetrahydrocannabinols. Pharmacol Biochem Behav (1976) 0.76
Antagonism of the morphine-induced locomotor activation of mice by fructose: comparison with other opiates and sugars, and sugar effects on brain morphine. Life Sci (1991) 0.75
Resistance exercise decreases beta-endorphin immunoreactivity. Br J Sports Med (1994) 0.75
Various factors which affect the rate of development of tolerance and physical dependence to abused drugs. NIDA Res Monogr (1984) 0.75
Beta-endorphin response to endurance exercise: relationship to exercise dependence. Percept Mot Skills (1993) 0.75
Effect of sleep loss on beta-endorphin activity, epinephrine levels, and ventilatory responsiveness. South Med J (1987) 0.75
Morphine dependence and diabetes. I. The development of morphine dependence in streptozotocin-diabetic rats and spontaneously diabetic C57BL/KsJ mice. J Pharmacol Exp Ther (1986) 0.75
Bad manners, not good. Nature (1995) 0.75